Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

Presentation TCT 2020

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

Presenter: Vijay Thakore

October 14, 2020

Presentation TCT 2020

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

Presenter: Hui Ying Ang

October 14, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

Presentation TCT 2019

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Presenter: Sahil Parikh

September 27, 2019

Presentation TCT 2019

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

Presenter: Sriram Iyer

September 27, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

Presentation TCT 2018

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Presenter: George L Adams, Tony Das, Gireesh Warwadekar

September 21, 2018

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

Advertisement

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

TCTMD’s Top 10 Most Popular Stories for February 2019

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content